Skip to main content

UBS Group AG

Position in ALDX — Aldeyra Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ALDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$643,131
-$265,359 QoQ
Shares Held
301,940
-43.8% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 108 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALDX Over Time

Shares Held

Position Value (USD)

Derivatives in ALDX

reported options exposure · as of Dec 31, 2021
CallValue
$80,000
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. ALDX ranks #280 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALDX

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $643,131 301,940
2026-03-31 $908,490 537,569
2025-12-31 $495,606 95,677
2025-09-30 $1,047,857 200,739
2025-06-30 $410,778 107,253
2025-03-31 $543,201 94,470
2024-12-31 $470,432 94,275
2024-09-30 $142,991 26,529
2024-06-30 $158,966 48,026
2024-03-31 $157,993 48,316
2023-12-31 $186,300 53,077
2023-09-30 $498,294 74,595
2023-06-30 $748,631 89,229
2023-03-31 $63,631 6,408
2022-12-31 $12,528 1,800
2022-09-30 $137,788 25,803
2022-06-30 $3,034,382 760,497
2022-03-31 $4,268,946 960,393
2021-12-31 $80,000 20,000
2021-12-31 $735,200 183,800
2021-09-30 $1,204,466 137,183
2021-06-30 $168,545 14,876
2021-03-31 $581,015 48,907
2020-12-31 $702,326 102,380
2020-09-30 $785,763 106,041
2020-06-30 $13,419 3,218
2020-03-31 $37,430 15,154